# OnCo record met-exon-14-skipping (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/met-exon-14-skipping/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "met-exon-14-skipping" ;
  schema:name "MET exon 14 skipping mutation"@en ;
  schema:alternateName "MET exon 14"@en, "METex14"@en, "MET ex14"@en, "MET exon 14 skipping"@en, "MET splice-site mutation"@en, "METex14 skipping alteration"@en, "c-Met immunohistochemistry"@en, "c-Met IHC"@en, "MET overexpression"@en, "MET copy number"@en, "MET-altered"@en ;
  schema:description "A splice-site mutation that makes cells skip exon 14 of the MET gene removes the receptor's off switch, so MET piles up on the cell surface; found in about 3 percent of lung adenocarcinomas, typically in older smokers or never-smokers, it is targeted by the pills capmatinib, tepotinib and savolitinib."@en ;
  schema:url <https://onco.cc/terms/met-exon-14-skipping/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:related <https://onco.cc/targets/met/>, <https://onco.cc/terms/met-amplification/>, <https://onco.cc/drugs/capmatinib/>, <https://onco.cc/drugs/tepotinib/>, <https://onco.cc/drugs/savolitinib/>, <https://onco.cc/drugs/crizotinib/>, <https://onco.cc/drugs/telisotuzumab-vedotin/>, <https://onco.cc/technologies/rna-seq/>, <https://onco.cc/terms/gatekeeper-mutation/> ;
  onco:cancers <https://onco.cc/cancers/met-altered-nsclc/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/papillary-rcc/> .